General Information of DTT (ID: TTXJ178)

DTT Name Histamine H4 receptor (H4R) DTT Info
Gene Name HRH4

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
JNJ-38518168 DM9UMIO Plaque psoriasis EA90.0 Phase 2 [1]
PF-3893787 DMC2FAL Atopic dermatitis EA80 Phase 2 [2]
UR-63325 DME6X27 Allergic rhinitis CA08.0 Phase 2 [3]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Thioperamide DM8S593 Cognitive impairment 6D71 Terminated [4]
------------------------------------------------------------------------------------
30 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(1H-indol-2-yl)(piperazin-1-yl)methanone DMW15DS Discovery agent N.A. Investigative [5]
(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate DMCSHI3 Discovery agent N.A. Investigative [6]
(R)-alpha-methylhistamine DMKAW4P Discovery agent N.A. Investigative [7]
(S)-alpha-methylhistamine DMTUZIN Discovery agent N.A. Investigative [8]
2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole DMZVBPG Discovery agent N.A. Investigative [9]
2-(3-bromophenyl)histamine DM260RG Discovery agent N.A. Investigative [10]
2-methylhistamine DMD8CQS Discovery agent N.A. Investigative [11]
4-methylhistamine DMABMPQ Discovery agent N.A. Investigative [11]
6-(4-Methylpiperazin-1-yl)-9H-purin-2-amine DMWITYU Discovery agent N.A. Investigative [12]
6-(4-methylpiperazin-1-yl)-9Hpurine DMA3FQP Discovery agent N.A. Investigative [12]
6-(4-Methylpiperazin-1-yl)pyrimidine-2,4-diamine DMYAS2V Discovery agent N.A. Investigative [12]
9-benzyl-6-(4-methylpiperazin-1-yl)-9H-purine DM4JG60 Discovery agent N.A. Investigative [12]
A-846714 DM5TDEW Discovery agent N.A. Investigative [13]
A-943931 DMROD7Q Discovery agent N.A. Investigative [13]
burimamide DMZ2VYG Discovery agent N.A. Investigative [14]
Clobenpropit DM537OH Discovery agent N.A. Investigative [15]
HTMT DMPT8JN Discovery agent N.A. Investigative [16]
Imetit DMMJ6NS Discovery agent N.A. Investigative [17]
improgan DMQ4ICU Discovery agent N.A. Investigative [16]
impromidine DMTDRPM Discovery agent N.A. Investigative [10]
JNJ-10191584 DM6P1UA Discovery agent N.A. Investigative [18]
N,N-dimethylhistamine DM8WPD2 Discovery agent N.A. Investigative [11]
N-ethylhistamine DMYI87T Discovery agent N.A. Investigative [11]
N-methylhistamine DMCFH5W Discovery agent N.A. Investigative [14]
N-[3H]alpha-methylhistamine DMWDCV1 Discovery agent N.A. Investigative [19]
N-[3H]methylhistamine DM0CI4L Discovery agent N.A. Investigative [7]
UR-60427 DM3YE5X Asthma CA23 Investigative [20]
VUF 8430 DMJC0UH Discovery agent N.A. Investigative [21]
[125I]iodophenpropit DMN4ABU Discovery agent N.A. Investigative [22]
[3H]JNJ 7777120 DMZT8UD Inflammation 1A00-CA43.1 Investigative [23]
------------------------------------------------------------------------------------
⏷ Show the Full List of 30 Investigative Drug(s)
Molecule Interaction Atlas

References

1 The histamine H4 receptor: from orphan to the clinic. Front Pharmacol. 2015; 6: 65.
2 Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6596-602.
3 Azines as histamine H4 receptor antagonists. Front Biosci (Schol Ed). 2012 Jan 1;4:967-87.
4 Role of histamine in short- and long-term effects of methamphetamine on the developing mouse brain. J Neurochem. 2008 Nov;107(4):976-86.
5 Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists. J Med Chem. 2005 Dec 29;48(26):8289-98.
6 Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6682-5.
7 Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol. 2001 Mar;59(3):420-6.
8 Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther. 2001 Mar;296(3):1058-66.
9 Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorg Med Chem. 2010 Jul 15;18(14):5441-8.
10 Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first pote... J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21.
11 Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives. Br J Pharmacol. 2006 Apr;147(7):744-54.
12 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization. Bioorg Med Chem. 2009 Oct 15;17(20):7186-96.
13 Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and... J Med Chem. 2008 Oct 23;51(20):6547-57.
14 Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther. 2001 Oct;299(1):121-30.
15 Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR s... Bioorg Med Chem. 2009 Jun 1;17(11):3987-94.
16 Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol. 2001 Mar;59(3):434-41.
17 Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors. J Neurophysiol. 2006 Apr;95(4):2492-500.
18 Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5251-6.
19 Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol. 2003 Nov;140(6):1117-27.
20 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 265).
21 Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. J Med Chem. 2006 Nov 16;49(23):6650-1.
22 Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. J Med Chem. 2008 Jun 12;51(11):3145-53.
23 A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther. 2004 Apr;309(1):404-13.